Sort
39,280 grants matching “leukemia”
Therapeutic targeting of growth factor receptors to treat Mucormycosis
$492,353Vincent Michael Bruno · University Of Maryland Baltimore · R01 · FY2023 · AI
Analysis of Nematode Sex Determination
$492,350Barbara J Meyer · University Of California Berkeley · R01 · FY2008 · GM
INNATE IMMUNE THERAPIES IN B CELL MALIGNANCIES
$492,345John C Byrd · Ohio State University · P01 · FY2009 · CA
Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition
$492,237Kavindra Nath · University Of Pennsylvania · R01 · FY2023 · CA
Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition
$492,237Jerry D Glickson · University Of Pennsylvania · R01 · FY2022 · CA
HIGH THROUGHPUT METHYLATION ANALYSIS IN CANCER
$492,211University Of Missouri-Columbia · R33 · FY2002 · CA
Project 4: Secondary Cancers Among NF1 Cancer Survivors
$492,187Jean Nakamura · Indiana University Indianapolis · U54 · FY2016 · CA
Mechanisms of STING in malignant progression and therapy of CLL.
$492,142Chih-Chi Andrew Hu · Methodist Hospital Research Institute · R01 · FY2023 · CA
Mechanisms of STING in malignant progression and therapy of CLL.
$492,142Chih-Chi Andrew Hu · Methodist Hospital Research Institute · R01 · FY2025 · CA
Designing T cells to Functionally Cure HIV-1 infection
$492,087James L Riley · University Of Pennsylvania · U19 · FY2016 · AI
Treatment of Bcr/Abl caused leukemias with FTIs
$492,085Nora C Heisterkamp · Children'S Hospital Of Los Angeles · R01 · FY2009 · CA
EZH2 in cancer biology and novel inhibitors
$492,047Jun Qi · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Carrier Mediated Antifolate Transport and Resistance
$492,000Albert Einstein Col Of Med Yeshiva Univ · R01 · FY2004 · CA
Characterizing and Targeting the Epigenetic Mechanisms Maintaining Neuroblastoma Tumor Initiating Cells
$492,000Saurabh Agarwal · St. John'S University · R15 · FY2023 · CA
THE APL PARADIGM FOR ABERRANT TRANSCRIPTION, CANCER AND
$491,961Sloan-Kettering Institute For Cancer Res · U01 · FY2000 · CA
Characterization and targeting of leukemia stem cell metabolism
$491,936Craig T. Jordan · University Of Colorado Denver · R01 · FY2018 · CA
Characterization and targeting of leukemia stem cell metabolism
$491,936Craig T. Jordan · University Of Colorado Denver · R01 · FY2017 · CA
Characterization and targeting of leukemia stem cell metabolism
$491,936Craig T. Jordan · University Of Colorado Denver · R01 · FY2020 · CA
SENP:Conformational Dynamics and Inhibition by Small Molecules
$491,778Yuan Chen · Beckman Research Institute/City Of Hope · R01 · FY2014 · GM
Predictors of Adult Leukemia
$491,742Julie Ann Ross · University Of Minnesota · R01 · FY2009 · CA
Targeted Inhibition in Leukemia
$491,521Nicolas Nassar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · CA
Targeted Inhibition in Leukemia
$491,521Nicolas Nassar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2022 · CA
Human and System Factors Contributing To Pediatric Medication Error and Injury
$491,516Kathleen Elizabeth Walsh · Cincinnati Childrens Hosp Med Ctr · R01 · FY2016 · HS
DISSECTING THE ROLE OF PRDM15 IN NORMAL HEMATOPOIESIS AND B-CELL MALIGNANCIES
$491,507Ernesto Guccione · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA
Identification of small molecule modulators of mitochondrial creatine kinase 1
$491,439Eduard A. Sergienko · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · CA